Skip to search formSkip to main contentSkip to account menu

Decapeptyl

Known as: Decapeptyl Depot, Decapeptyl LP, Decapeptyl Trimestral 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Triptorelintriptorelin pamoate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
BACKGROUND Heavy menstrual bleeding is one of the most common reasons for referral of premenopausal women to a gynaecologist… 
2006
2006
Endocrine, morphological, and cytological effects of a depot GnRH agonist in bovine.
2003
2003
Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment.
2000
2000
Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, cetrorelix, and GnRH agonists.
1998
1998
Changes in body composition in women treated with gonadotropin-releasing hormone agonists.
Review
1998
Review
1998
Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review.
1991
1991
Influence of luteinizing hormone-releasing hormone agonists on human mammary carcinoma cell lines and their xenografts
Highly Cited
1990
Highly Cited
1990
Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3.
Estrogen deficiency results in bone mass reduction of largely varying extent in postmenopausal females, indicating that… 
Highly Cited
1989
Highly Cited
1989
Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability.
A retrospective analysis was performed in order to compare the number and quality of oocytes recovered in in-vitro fertilization… 
Review
1988
Review
1988
Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules.
Forty-one patients with advanced ovarian cancer (FIGO stage III or IV) who had relapsed following conventional treatment were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)